Neural substrates underlying effort computation in schizophrenia

Neuroscience and Biobehavioral Reviews

Volumn 37, Issue 10, 2013, Pages 2649-2665

  Fervaha, Gagan ^a,b   Foussias, George ^a,b,c   Agid, Ofer ^a,c   Remington, Gary ^a,b,c  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Amotivation; Anterior cingulate cortex; Apathy; Avolition; Cost benefit decision making; Dopamine; Effort; Motivation; Negative symptoms; Reward; Schizophrenia

Indexed keywords

ADENOSINE; AMPHETAMINE; CHLORPROMAZINE; DOPAMINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; ESTRADIOL; LISDEXAMFETAMINE; MONOAMINE OXIDASE INHIBITOR;

ANTERIOR CINGULATE; ATTENTION DEFICIT DISORDER; AUTISM; BASAL GANGLION; BRAIN DEPTH STIMULATION; CLINICAL ASSESSMENT; COGNITIVE THERAPY; COST BENEFIT ANALYSIS; DECISION MAKING; DOPAMINE BRAIN LEVEL; DRUG EFFICACY; EXECUTIVE FUNCTION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GLOBUS PALLIDUS; HUMAN; META ANALYSIS (TOPIC); MOTIVATION; NEUROPATHOLOGY; NONHUMAN; NUCLEUS ACCUMBENS; ORBITAL CORTEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCHIZOPHRENIA; SINGLE DRUG DOSE; TRANSCRANIAL MAGNETIC STIMULATION;

AMOTIVATION; ANTERIOR CINGULATE CORTEX; APATHY; AVOLITION; COST-BENEFIT DECISION MAKING; DOPAMINE; EFFORT; MOTIVATION; NEGATIVE SYMPTOMS; REWARD; SCHIZOPHRENIA;

ANIMALS; COGNITIVE DISSONANCE; DECISION MAKING; GOALS; HUMANS; MOTIVATION; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84889681332     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2013.09.001     Document Type: Review

References (379)

1. Abler B., Erk S., Walter H. Human reward system activation is modulated by a single dose of olanzapine in healthy subjects in an event-related, double-blind, placebo-controlled fMRI study. Psychopharmacology (Berl.) 2007, 191:823-833.
2. Agay N., Kron S., Carmel Z., Mendlovic S., Levkovitz Y. Ultimatum bargaining behavior of people affected by schizophrenia. Psychiatry Res. 2008, 157:39-46.
3. Aharon I., Etcoff N., Ariely D., Chabris C.F., O'Connor E., Breiter H.C. Beautiful faces have variable reward value: fMRI and behavioral evidence. Neuron 2001, 32:537-551.
4. Ahn W.Y., Rass O., Fridberg D.J., Bishara A.J., Forsyth J.K., Breier A., Busemeyer J.R., Hetrick W.P., Bolbecker A.R., O'Donnell B.F. Temporal discounting of rewards in patients with bipolar disorder and schizophrenia. J. Abnorm. Psychol. 2011, 120:911-921.
5. Akerlof G.A., Yellen J.L. The fair wage-effort hypothesis and unemployment. Q. J. Econ. 1990, 105:255-283.
6. Alessandri J., Darcheville J.C., Delevoye-Turrell Y., Zentall T.R. Preference for rewards that follow greater effort and greater delay. Learn. Behav. 2008, 36:352-358.
7. An K.Y., Zakzanis K.K., Joordens S. Conducting research with non-clinical healthy undergraduates: does effort play a role in neuropsychological test performance?. Arch. Clin. Neuropsychol. 2012, 27:849-857.
8. Andreasen N.C. Negative symptoms in schizophrenia. Definition and reliability. Arch. Gen. Psychiatry 1982, 39:784-788.
9. Andreasen N.C., Arndt S., Alliger R., Miller D., Flaum M. Symptoms of schizophrenia. Methods, meanings, and mechanisms. Arch. Gen. Psychiatry 1995, 52:341-351.
10. Angrist B., Peselow E., Rubinstein M., Corwin J., Rotrosen J. Partial improvement in negative schizophrenic symptoms after amphetamine. Psychopharmacology (Berl.) 1982, 78:128-130.
11. Aronson E., Mills J. The effect of severity of initiation on liking for a group. J. Abnorm. Soc. Psychol. 1959, 59:177.
12. Artaloytia J.F., Arango C., Lahti A., Sanz J., Pascual A., Cubero P., Prieto D., Palomo T. Negative signs and symptoms secondary to antipsychotics: a double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers. Am. J. Psychiatry 2006, 163:488-493.
13. Assadi S.M., Yucel M., Pantelis C. Dopamine modulates neural networks involved in effort-based decision-making. Neurosci. Biobehav. Rev. 2009, 33:383-393.
14. Avery R., Startup M., Calabria K. The role of effort, cognitive expectancy appraisals and coping style in the maintenance of the negative symptoms of schizophrenia. Psychiatry Res. 2009, 167:36-46.
15. Aw J.M., Vasconcelos M., Kacelnik A. How costs affect preferences: experiments on state dependence, hedonic state and within-trial contrast in starlings. Anim. Behav. 2011, 81:1117-1128.
16. Baek K., Kim Y.T., Kim M., Choi Y., Lee M., Lee K., Hahn S., Jeong J. Response randomization of one- and two-person rock-paper-scissors games in individuals with schizophrenia. Psychiatry Res. 2013, 207:158-163.
17. Baiano M., David A., Versace A., Churchill R., Balestrieri M., Brambilla P. Anterior cingulate volumes in schizophrenia: a systematic review and a meta-analysis of MRI studies. Schizophr. Res. 2007, 93:1-12.
18. Barch D.M., Braver T.S., Nystrom L.E., Forman S.D., Noll D.C., Cohen J.D. Dissociating working memory from task difficulty in human prefrontal cortex. Neuropsychologia 1997, 35:1373-1380.
19. Barch D.M., Carter C.S., Braver T.S., Sabb F.W., MacDonald A., Noll D.C., Cohen J.D. Selective deficits in prefrontal cortex function in medication-naive patients with schizophrenia. Arch. Gen. Psychiatry 2001, 58:280-288.
20. Barch D.M., Carter C.S., MacDonald A.W., Braver T.S., Cohen J.D. Context-processing deficits in schizophrenia: diagnostic specificity, 4-week course, and relationships to clinical symptoms. J. Abnorm. Psychol. 2003, 112:132-143.
21. Barch D.M., Dowd E.C. Goal representations and motivational drive in schizophrenia: the role of prefrontal-striatal interactions. Schizophr. Bull. 2010, 36:919-934.
22. Barch D.M., Yodkovik N., Sypher-Locke H., Hanewinkel M. Intrinsic motivation in schizophrenia: relationships to cognitive function, depression, anxiety, and personality. J. Abnorm. Psychol. 2008, 117:776-787.
23. Bardgett M.E., Depenbrock M., Downs N., Points M., Green L. Dopamine modulates effort-based decision making in rats. Behav. Neurosci. 2009, 123:242-251.
24. Barzel Y. The determination of daily hours and wages. Q. J. Econ. 1973, 87:220-238.
25. Bautista L.M., Tinbergen J., Kacelnik A. To walk or to fly? How birds choose among foraging modes. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:1089-1094.
26. Bechara A. Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective. Nat. Neurosci. 2005, 8:1458-1463.
27. Bell M.D., Mishara A.L. Does negative symptom change relate to neurocognitive change in schizophrenia? Implications for targeted treatments. Schizophr. Res. 2006, 81:17-27.
28. Bellack A.S., Mueser K.T., Morrison R.L., Tierney A., Podell K. Remediation of cognitive deficits in schizophrenia. Am. J. Psychiatry 1990, 147:1650-1655.
29. Benkert O., Muller-Siecheneder F., Wetzel H. Dopamine agonists in schizophrenia: a review. Eur. Neuropsychopharmacol. 1995, 5(Suppl):43-53.
30. Berenbaum H., Oltmanns T.F. Emotional experience and expression in schizophrenia and depression. J. Abnorm. Psychol. 1992, 101:37-44.
31. Berridge K.C., Robinson T.E. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?. Brain Res. Brain Res. Rev. 1998, 28:309-369.
32. Bewernick B.H., Hurlemann R., Matusch A., Kayser S., Grubert C., Hadrysiewicz B., Axmacher N., Lemke M., Cooper-Mahkorn D., Cohen M.X., Brockmann H., Lenartz D., Sturm V., Schlaepfer T.E. Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biol. Psychiatry 2010, 67:110-116.
33. Bewernick B.H., Kayser S., Sturm V., Schlaepfer T.E. Long-term effects of nucleus accumbens deep brain stimulation in treatment-resistant depression: evidence for sustained efficacy. Neuropsychopharmacology 2012, 37:1975-1985.
34. Blanchard J.J., Cohen A.S. The structure of negative symptoms within schizophrenia: implications for assessment. Schizophr. Bull. 2006, 32:238-245.
35. Blanchard J.J., Mueser K.T., Bellack A.S. Anhedonia, positive and negative affect, and social functioning in schizophrenia. Schizophr. Bull. 1998, 24:413-424.
36. Bleuler E. Dementia Praecox or the Group of Schizophrenias 1950, International Universities Press, New York.
37. Bodkin J.A., Siris S.G., Bermanzohn P.C., Hennen J., Cole J.O. Double-blind, placebo-controlled, multicenter trial of selegiline augmentation of antipsychotic medication to treat negative symptoms in outpatients with schizophrenia. Am. J. Psychiatry 2005, 162:388-390.
38. Bonner S.E., Sprinkle G.B. The effects of monetary incentives on effort and task performance: theories, evidence, and a framework for research. Account. Org. Soc. 2002, 27:303-345.
39. Botvinick M.M., Cohen J.D., Carter C.S. Conflict monitoring and anterior cingulate cortex: an update. Trends Cogn. Sci. 2004, 8:539-546.
40. Botvinick M.M., Huffstetler S., McGuire J.T. Effort discounting in human nucleus accumbens. Cogn. Affect. Behav. Neurosci. 2009, 9:16-27.
41. Brambilla P., Perlini C., Bellani M., Tomelleri L., Ferro A., Cerruti S., Marinelli V., Rambaldelli G., Christodoulou T., Jogia J., Dima D., Tansella M., Balestrieri M., Frangou S. Increased salience of gains versus decreased associative learning differentiate bipolar disorder from schizophrenia during incentive decision making. Psychol. Med. 2013, 43:571-580.
42. Brown J.K., Waltz J.A., Strauss G.P., McMahon R.P., Frank M.J., Gold J.M. Hypothetical decision making in schizophrenia: The role of expected value computation and "irrational" biases. Psychiatry Res. 2013, 209:142-149.
43. Brown J.W., Braver T.S. Learned predictions of error likelihood in the anterior cingulate cortex. Science 2005, 307:1118-1121.
44. Brown R.G., Pluck G. Negative symptoms: the 'pathology' of motivation and goal-directed behaviour. Trends Neurosci. 2000, 23:412-417.
45. Burbridge J.A., Barch D.M. Anhedonia and the experience of emotion in individuals with schizophrenia. J. Abnorm. Psychol. 2007, 116:30-42.
46. Bush G., Luu P., Posner M.I. Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn. Sci. 2000, 4:215-222.
47. Bustillo J.R., Rowland L.M., Mullins P., Jung R., Chen H., Qualls C., Hammond R., Brooks W.M., Lauriello J. 1H-MRS at 4 tesla in minimally treated early schizophrenia. Mol. Psychiatry 2010, 15:629-636.
48. Cacioppo J.T., Petty R.E. The need for cognition. J. Pers. Soc. Psychol. 1982, 42:116.
49. Camisa K.M., Bockbrader M.A., Lysaker P., Rae L.L., Brenner C.A., O'Donnell B.F. Personality traits in schizophrenia and related personality disorders. Psychiatry Res. 2005, 133:23-33.
50. Cannon C.M., Palmiter R.D. Reward without dopamine. J. Neurosci. 2003, 23:10827-10831.
51. Carpenter W.T., Breier A., Buchanan R.W., Kirkpatrick B., Shepard P., Weiner E. Mazindol treatment of negative symptoms. Neuropsychopharmacology 2000, 23:365-374.
52. Carpenter W.T., Heinrichs D.W., Wagman A.M. Deficit and nondeficit forms of schizophrenia: the concept. Am. J. Psychiatry 1988, 145:578-583.
53. Carter C.S., MacDonald A.W., Ross L.L., Stenger V.A. Anterior cingulate cortex activity and impaired self-monitoring of performance in patients with schizophrenia: an event-related fMRI study. Am. J. Psychiatry 2001, 158:1423-1428.
54. Chapman L.J., Chapman J.P., Raulin M.L. Scales for physical and social anhedonia. J. Abnorm. Psychol. 1976, 85:374-382.
55. Chelonis J.J., Gravelin C.R., Paule M.G. Assessing motivation in children using a progressive ratio task. Behav. Process. 2011, 87:203-209.
56. Chelonis J.J., Johnson T.A., Ferguson S.A., Berry K.J., Kubacak B., Edwards M.C., Paule M.G. Effect of methylphenidate on motivation in children with attention-deficit/hyperactivity disorder. Exp. Clin. Psychopharmacol. 2011, 19:145-153.
57. Choi J., Mogami T., Medalia A. Intrinsic motivation inventory: an adapted measure for schizophrenia research. Schizophr. Bull. 2010, 36:966-976.
58. Chung D., Kim Y.T., Jeong J. Cognitive motivations of free riding and cooperation and impaired strategic decision making in schizophrenia during a public goods game. Schizophr. Bull. 2013, 39:112-119.
59. Clement T.S., Feltus J.R., Kaiser D.H., Zentall T.R. Work ethic" in pigeons: reward value is directly related to the effort or time required to obtain the reward. Psychon. Bull. Rev. 2000, 7:100-106.
60. Clementz B.A., Grove W.M., Katsanis J., Iacono W.G. Psychometric detection of schizotypy: perceptual aberration and physical anhedonia in relatives of schizophrenics. J. Abnorm. Psychol. 1991, 100:607-612.
61. Clery-Melin M.L., Schmidt L., Lafargue G., Baup N., Fossati P., Pessiglione M. Why don't you try harder? An investigation of effort production in major depression. PLoS ONE 2011, 6:e23178.
62. Cocker P.J., Hosking J.G., Benoit J., Winstanley C.A. Sensitivity to cognitive effort mediates psychostimulant effects on a novel rodent cost/benefit decision-making task. Neuropsychopharmacology 2012, 37:1825-1837.
63. Cohen A.S., Minor K.S. Emotional experience in patients with schizophrenia revisited: meta-analysis of laboratory studies. Schizophr. Bull. 2010, 36:143-150.
64. Cohen J.D., Barch D.M., Carter C., Servan-Schreiber D. Context-processing deficits in schizophrenia: converging evidence from three theoretically motivated cognitive tasks. J. Abnorm. Psychol. 1999, 108:120-133.
65. Cousins M.S., Salamone J.D. Nucleus accumbens dopamine depletions in rats affect relative response allocation in a novel cost/benefit procedure. Pharmacol. Biochem. Behav. 1994, 49:85-91.
66. Cowen S.L., Davis G.A., Nitz D.A. Anterior cingulate neurons in the rat map anticipated effort and reward to their associated action sequences. J. Neurophysiol. 2012, 107:2393-2407.
67. Craver J.C., Pogue-Geile M.F. Familial liability to schizophrenia: a sibling study of negative symptoms. Schizophr. Bull. 1999, 25:827-839.
68. Crespo-Facorro B., Paradiso S., Andreasen N.C., O'Leary D.S., Watkins G.L., Ponto L.L., Hichwa R.D. Neural mechanisms of anhedonia in schizophrenia: a PET study of response to unpleasant and pleasant odors. JAMA 2001, 286:427-435.
69. Croxson P.L., Walton M.E., O'Reilly J.X., Behrens T.E., Rushworth M.F. Effort-based cost-benefit valuation and the human brain. J. Neurosci. 2009, 29:4531-4541.
70. Csukly G., Polgar P., Tombor L., Rethelyi J., Keri S. Are patients with schizophrenia rational maximizers? Evidence from an ultimatum game study. Psychiatry Res. 2011, 187:11-17.
71. Cummings J.L. Frontal-subcortical circuits and human behavior. Arch. Neurol. 1993, 50:873-880.
72. Cuthbert B.N., Insel T.R. Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med. 2013, 11:126.
73. D'Argembeau A., Raffard S., Van der Linden M. Remembering the past and imagining the future in schizophrenia. J. Abnorm. Psychol. 2008, 117:247-251.
74. Damiano C.R., Aloi J., Treadway M., Bodfish J.W., Dichter G.S. Adults with autism spectrum disorders exhibit decreased sensitivity to reward parameters when making effort-based decisions. J. Neurodev. Disord. 2012, 4:13.
75. Day J.J., Jones J.L., Carelli R.M. Nucleus accumbens neurons encode predicted and ongoing reward costs in rats. Eur. J. Neurosci. 2011, 33:308-321.
76. Day J.J., Jones J.L., Wightman R.M., Carelli R.M. Phasic nucleus accumbens dopamine release encodes effort- and delay-related costs. Biol. Psychiatry 2010, 68:306-309.
77. de Haan L., Lavalaye J., Linszen D., Dingemans P.M., Booij J. Subjective experience and striatal dopamine D(2) receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone. Am. J. Psychiatry 2000, 157:1019-1020.
78. de Haan L., van Bruggen M., Lavalaye J., Booij J., Dingemans P.M., Linszen D. Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study. Am. J. Psychiatry 2003, 160:303-309.
79. de Oliveira H., Cuervo-Lombard C., Salame P., Danion J.M. Autonoetic awareness associated with the projection of the self into the future: an investigation in schizophrenia. Psychiatry Res. 2009, 169:86-87.
80. Deci E.L., Koestner R., Ryan R.M. A meta-analytic review of experiments examining the effects of extrinsic rewards on intrinsic motivation. Psychol. Bull. 1999, 125:627-668. (discussion 692-700).
81. Denk F., Walton M.E., Jennings K.A., Sharp T., Rushworth M.F., Bannerman D.M. Differential involvement of serotonin and dopamine systems in cost-benefit decisions about delay or effort. Psychopharmacology (Berl.) 2005, 179:587-596.
82. Der-Avakian A., Markou A. The neurobiology of anhedonia and other reward-related deficits. Trends Neurosci. 2012, 35:68-77.
83. Devinsky O., Morrell M.J., Vogt B.A. Contributions of anterior cingulate cortex to behaviour. Brain 1995, 118(Pt 1):279-306.
84. Dixon M.L., Christoff K. The decision to engage cognitive control is driven by expected reward-value: neural and behavioral evidence. PLoS ONE 2012, 7:e51637.
85. Dlabac-de Lange J.J., Knegtering R., Aleman A. Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: review and meta-analysis. J. Clin. Psychiatry 2010, 71:411-418.
86. Dowd E.C., Barch D.M. Anhedonia and emotional experience in schizophrenia: neural and behavioral indicators. Biol. Psychiatry 2010, 67:902-911.
87. Dowd E.C., Barch D.M. Pavlovian reward prediction and receipt in schizophrenia: relationship to anhedonia. PLoS ONE 2012, 7:e35622.
88. Doya K. Modulators of decision making. Nat. Neurosci. 2008, 11:410-416.
89. Dreher J.C. Neural coding of computational factors affecting decision making. Prog. Brain Res. 2013, 202:289-320.
90. Earnst K.S., Kring A.M. Construct validity of negative symptoms: an empirical and conceptual review. Clin. Psychol. Rev. 1997, 17:167-189.
91. Eccles J.S., Wigfield A. Motivational beliefs, values, and goals. Annu. Rev. Psychol. 2002, 53:109-132.
92. Egerton A., Brugger S., Raffin M., Barker G.J., Lythgoe D.J., McGuire P.K., Stone J.M. Anterior cingulate glutamate levels related to clinical status following treatment in first-episode schizophrenia. Neuropsychopharmacology 2012, 37:2515-2521.
93. Eisenberger R. Learned industriousness. Psychol. Rev. 1992, 99:248-267.
94. Ellison-Wright I., Glahn D.C., Laird A.R., Thelen S.M., Bullmore E. The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. Am. J. Psychiatry 2008, 165:1015-1023.
95. Emsley R.A., Niehaus D.J., Mbanga N.I., Oosthuizen P.P., Stein D.J., Maritz J.S., Pimstone S.N., Hayden M.R., Laurent C., Deleuze J.F., Mallet J. The factor structure for positive and negative symptoms in South African Xhosa patients with schizophrenia. Schizophr. Res. 2001, 47:149-157.
96. Endepols H., Sommer S., Backes H., Wiedermann D., Graf R., Hauber W. Effort-based decision making in the rat: an [18F]fluorodeoxyglucose micro positron emission tomography study. J. Neurosci. 2010, 30:9708-9714.
97. Enticott P.G., Ogloff J.R., Bradshaw J.L. Response inhibition and impulsivity in schizophrenia. Psychiatry Res. 2008, 157:251-254.
98. Ernst M., Paulus M.P. Neurobiology of decision making: a selective review from a neurocognitive and clinical perspective. Biol. Psychiatry 2005, 58:597-604.
99. Esslinger C., Englisch S., Inta D., Rausch F., Schirmbeck F., Mier D., Kirsch P., Meyer-Lindenberg A., Zink M. Ventral striatal activation during attribution of stimulus saliency and reward anticipation is correlated in unmedicated first episode schizophrenia patients. Schizophr. Res. 2012, 140:114-121.
100. Faerden A., Finset A., Friis S., Agartz I., Barrett E.A., Nesvag R., Andreassen O.A., Marder S.R., Melle I. Apathy in first episode psychosis patients: one year follow up. Schizophr. Res 2010, 116:20-26.
101. Faerden A., Nesvag R., Barrett E.A., Agartz I., Finset A., Friis S., Rossberg J.I., Melle I. Assessing apathy: the use of the Apathy Evaluation Scale in first episode psychosis. Eur. Psychiatry 2008, 23:33-39.
102. Faerden A., Vaskinn A., Finset A., Agartz I., Ann Barrett E., Friis S., Simonsen C., Andreassen O.A., Melle I. Apathy is associated with executive functioning in first episode psychosis. BMC Psychiatry 2009, 9:1.
103. Farrar A.M., Font L., Pereira M., Mingote S., Bunce J.G., Chrobak J.J., Salamone J.D. Forebrain circuitry involved in effort-related choice: Injections of the GABAA agonist muscimol into ventral pallidum alter response allocation in food-seeking behavior. Neuroscience 2008, 152:321-330.
104. Farrar A.M., Pereira M., Velasco F., Hockemeyer J., Muller C.E., Salamone J.D. Adenosine A(2A) receptor antagonism reverses the effects of dopamine receptor antagonism on instrumental output and effort-related choice in the rat: implications for studies of psychomotor slowing. Psychopharmacology (Berl.) 2007, 191:579-586.
105. Farrar A.M., Segovia K.N., Randall P.A., Nunes E.J., Collins L.E., Stopper C.M., Port R.G., Hockemeyer J., Muller C.E., Correa M., Salamone J.D. Nucleus accumbens and effort-related functions: behavioral and neural markers of the interactions between adenosine A2A and dopamine D2 receptors. Neuroscience 2010, 166:1056-1067.
106. Farrow T.F., Hunter M.D., Wilkinson I.D., Green R.D., Spence S.A. Structural brain correlates of unconstrained motor activity in people with schizophrenia. Br. J. Psychiatry 2005, 187:481-482.
107. Fervaha G., Foussias G., Agid O., Remington G. Amotivation and functional outcomes in early schizophrenia. Psychiatry Res. 2013, 10.1016/j.psychres.2013.07.024.
108. Fitzgerald P.B., Herring S., Hoy K., McQueen S., Segrave R., Kulkarni J., Daskalakis Z.J. A study of the effectiveness of bilateral transcranial magnetic stimulation in the treatment of the negative symptoms of schizophrenia. Brain Stimulat. 2008, 1:27-32.
109. Floresco S.B., Ghods-Sharifi S. Amygdala-prefrontal cortical circuitry regulates effort-based decision making. Cereb. Cortex 2007, 17:251-260.
110. Floresco S.B., Tse M.T., Ghods-Sharifi S. Dopaminergic and glutamatergic regulation of effort- and delay-based decision making. Neuropsychopharmacology 2008, 33:1966-1979.
111. Font L., Mingote S., Farrar A.M., Pereira M., Worden L., Stopper C., Port R.G., Salamone J.D. Intra-accumbens injections of the adenosine A2A agonist CGS 21680 affect effort-related choice behavior in rats. Psychopharmacology (Berl.) 2008, 199:515-526.
112. Foussias G., Mann S., Zakzanis K.K., van Reekum R., Agid O., Remington G. Prediction of longitudinal functional outcomes in schizophrenia: the impact of baseline motivational deficits. Schizophr. Res. 2011, 132:24-27.
113. Foussias G., Remington G. Negative symptoms in schizophrenia: avolition and Occam's razor. Schizophr. Bull. 2010, 36:359-369.
114. Frank M.J., Claus E.D. Anatomy of a decision: striato-orbitofrontal interactions in reinforcement learning, decision making, and reversal. Psychol. Rev. 2006, 113:300-326.
115. Franke P., Maier W., Hardt J., Hain C., Cornblatt B.A. Attentional abilities and measures of schizotypy: their variation and covariation in schizophrenic patients, their siblings, and normal control subjects. Psychiatry Res. 1994, 54:259-272.
116. Freedman R. Schizophrenia. N. Engl. J. Med. 2003, 349:1738-1749.
117. Friedrich A.M., Zentall T.R. Pigeons shift their preference toward locations of food that take more effort to obtain. Behav. Process. 2004, 67:405-415.
118. Friston K.J., Frith C.D. Schizophrenia: a disconnection syndrome?. Clin. Neurosci. 1995, 3:89-97.
119. Fu C.H., Morgan K., Suckling J., Williams S.C., Andrew C., Vythelingum G.N., McGuire P.K. A functional magnetic resonance imaging study of overt letter verbal fluency using a clustered acquisition sequence: greater anterior cingulate activation with increased task demand. NeuroImage 2002, 17:871-879.
120. Fu C.H., Suckling J., Williams S.C., Andrew C.M., Vythelingum G.N., McGuire P.K. Effects of psychotic state and task demand on prefrontal function in schizophrenia: an fMRI study of overt verbal fluency. Am. J. Psychiatry 2005, 162:485-494.
121. Gan J.O., Walton M.E., Phillips P.E. Dissociable cost and benefit encoding of future rewards by mesolimbic dopamine. Nat. Neurosci. 2010, 13:25-27.
122. Gard D.E., Kring A.M., Gard M.G., Horan W.P., Green M.F. Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure. Schizophr. Res. 2007, 93:253-260.
123. George M.S., Molnar C.E., Grenesko E.L., Anderson B., Mu Q., Johnson K., Nahas Z., Knable M., Fernandes P., Juncos J., Huang X., Nichols D.E., Mailman R.B. A single 20mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients with schizophrenia. Schizophr. Res. 2007, 93:42-50.
124. Ghods-Sharifi S., Floresco S.B. Differential effects on effort discounting induced by inactivations of the nucleus accumbens core or shell. Behav. Neurosci. 2010, 124:179-191.
125. Ghods-Sharifi S., St Onge J.R., Floresco S.B. Fundamental contribution by the basolateral amygdala to different forms of decision making. J. Neurosci. 2009, 29:5251-5259.
126. Glahn D.C., Laird A.R., Ellison-Wright I., Thelen S.M., Robinson J.L., Lancaster J.L., Bullmore E., Fox P.T. Meta-analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis. Biol. Psychiatry 2008, 64:774-781.
127. Glahn D.C., Ragland J.D., Abramoff A., Barrett J., Laird A.R., Bearden C.E., Velligan D.I. Beyond hypofrontality: a quantitative meta-analysis of functional neuroimaging studies of working memory in schizophrenia. Hum. Brain Mapp. 2005, 25:60-69.
128. Gold J.M., Strauss G.P., Waltz J.A., Robinson B.M., Brown J.K., Frank M.J. Negative symptoms of schizophrenia are associated with abnormal effort-cost computations. Biol. Psychiatry 2013, 74:130-136.
129. Gold J.M., Waltz J.A., Matveeva T.M., Kasanova Z., Strauss G.P., Herbener E.S., Collins A.G., Frank M.J. Negative symptoms and the failure to represent the expected reward value of actions: behavioral and computational modeling evidence. Arch. Gen. Psychiatry 2012, 69:129-138.
130. Gorissen M., Sanz J.C., Schmand B. Effort and cognition in schizophrenia patients. Schizophr. Res. 2005, 78:199-208.
131. Gradin V.B., Kumar P., Waiter G., Ahearn T., Stickle C., Milders M., Reid I., Hall J., Steele J.D. Expected value and prediction error abnormalities in depression and schizophrenia. Brain 2011, 134:1751-1764.
132. Granholm E., Verney S.P., Perivoliotis D., Miura T. Effortful cognitive resource allocation and negative symptom severity in chronic schizophrenia. Schizophr. Bull. 2007, 33:831-842.
133. Grant P.M., Huh G.A., Perivoliotis D., Stolar N.M., Beck A.T. Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia. Arch. Gen. Psychiatry 2012, 69:121-127.
134. Green M.F. What are the functional consequences of neurocognitive deficits in schizophrenia?. Am. J. Psychiatry 1996, 153:321-330.
135. Green M.F., Kern R.S., Braff D.L., Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?. Schizophr. Bull. 2000, 26:119-136.
136. Green M.F., Satz P., Ganzell S., Vaclav J.F. Wisconsin Card Sorting Test performance in schizophrenia: remediation of a stubborn deficit. Am. J. Psychiatry 1992, 149:62-67.
137. Green P., Rohling M.L., Lees-Haley P.R., Allen L.M. Effort has a greater effect on test scores than severe brain injury in compensation claimants. Brain Inj. 2001, 15:1045-1060.
138. Grimm O., Vollstadt-Klein S., Krebs L., Zink M., Smolka M.N. Reduced striatal activation during reward anticipation due to appetite-provoking cues in chronic schizophrenia: a fMRI study. Schizophr. Res. 2012, 134:151-157.
139. Haber S.N., Knutson B. The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology 2010, 35:4-26.
140. Harvey P.D., Koren D., Reichenberg A., Bowie C.R. Negative symptoms and cognitive deficits: what is the nature of their relationship?. Schizophr. Bull. 2006, 32:250-258.
141. Harvey P.O., Armony J., Malla A., Lepage M. Functional neural substrates of self-reported physical anhedonia in non-clinical individuals and in patients with schizophrenia. J. Psychiatr. Res. 2010, 44:707-716.
142. Hauber W., Sommer S. Prefrontostriatal circuitry regulates effort-related decision making. Cereb. Cortex 2009, 19:2240-2247.
143. Heerey E.A., Bell-Warren K.R., Gold J.M. Decision-making impairments in the context of intact reward sensitivity in schizophrenia. Biol. Psychiatry 2008, 64:62-69.
144. Heerey E.A., Gold J.M. Patients with schizophrenia demonstrate dissociation between affective experience and motivated behavior. J. Abnorm. Psychol. 2007, 116:268-278.
145. Heerey E.A., Matveeva T.M., Gold J.M. Imagining the future: degraded representations of future rewards and events in schizophrenia. J. Abnorm. Psychol. 2011, 120:483-489.
146. Heerey E.A., Robinson B.M., McMahon R.P., Gold J.M. Delay discounting in schizophrenia. Cognit. Neuropsychiatry 2007, 12:213-221.
147. Heinrichs R.W., Zakzanis K.K. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 1998, 12:426-445.
148. Hellman S.G., Kern R.S., Neilson L.M., Green M.F. Monetary reinforcement and Wisconsin Card Sorting performance in schizophrenia: why show me the money?. Schizophr. Res. 1998, 34:67-75.
149. Henry L.P., Amminger G.P., Harris M.G., Yuen H.P., Harrigan S.M., Prosser A.L., Schwartz O.S., Farrelly S.E., Herrman H., Jackson H.J., McGorry P.D. The EPPIC follow-up study of first-episode psychosis: longer-term clinical and functional outcome 7 years after index admission. J. Clin. Psychiatry 2010, 71:716-728.
150. Hillman K.L., Bilkey D.K. Neurons in the rat anterior cingulate cortex dynamically encode cost-benefit in a spatial decision-making task. J. Neurosci. 2010, 30:7705-7713.
151. Hillman K.L., Bilkey D.K. Neural encoding of competitive effort in the anterior cingulate cortex. Nat. Neurosci. 2012, 15:1290-1297.
152. Ho B.C., Nopoulos P., Flaum M., Arndt S., Andreasen N.C. Two-year outcome in first-episode schizophrenia: predictive value of symptoms for quality of life. Am. J. Psychiatry 1998, 155:1196-1201.
153. Hodos W. Progressive ratio as a measure of reward strength. Science 1961, 134:943-944.
154. Holroyd C.B., Coles M.G. The neural basis of human error processing: reinforcement learning, dopamine, and the error-related negativity. Psychol. Rev. 2002, 109:679-709.
155. Holroyd C.B., Yeung N. Motivation of extended behaviors by anterior cingulate cortex. Trends Cogn. Sci. 2012, 16:122-128.
156. Holt D.V., Wolf J., Funke J., Weisbrod M., Kaiser S. Planning impairments in schizophrenia: specificity, task independence and functional relevance. Schizophr. Res. 2013, 149:174-179.
157. Horan W.P., Green M.F., Kring A.M., Nuechterlein K.H. Does anhedonia in schizophrenia reflect faulty memory for subjectively experienced emotions?. J. Abnorm. Psychol. 2006, 115:496-508.
158. Horan W.P., Kring A.M., Gur R.E., Reise S.P., Blanchard J.J. Development and psychometric validation of the Clinical Assessment Interview for Negative Symptoms (CAINS). Schizophr. Res. 2011, 132:140-145.
159. Hull C. Principles of Behavior 1943, Appleton-Century-Crofts, Ney York, NY.
160. Insel T., Cuthbert B., Garvey M., Heinssen R., Pine D.S., Quinn K., Sanislow C., Wang P. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am. J. Psychiatry 2010, 167:748-751.
161. Izquierdo A., Carlos K., Ostrander S., Rodriguez D., McCall-Craddolph A., Yagnik G., Zhou F. Impaired reward learning and intact motivation after serotonin depletion in rats. Behav. Brain Res. 2012, 233:494-499.
162. Jandl M., Bittner R., Sack A., Weber B., Gunther T., Pieschl D., Kaschka W.P., Maurer K. Changes in negative symptoms and EEG in schizophrenic patients after repetitive transcranial magnetic stimulation (rTMS): an open-label pilot study. J. Neural Transm. 2005, 112:955-967.
163. Jaskiw G.E., Popli A.P. A meta-analysis of the response to chronic L-dopa in patients with schizophrenia: therapeutic and heuristic implications. Psychopharmacology (Berl.) 2004, 171:365-374.
164. Jessen F., Fingerhut N., Sprinkart A.M., Kuhn K.U., Petrovsky N., Maier W., Schild H.H., Block W., Wagner M., Traber F. N-acetylaspartylglutamate (NAAG) and N-acetylaspartate (NAA) in patients with schizophrenia. Schizophr. Bull. 2013, 39:197-205.
165. Johnson A.W., Gallagher M. Greater effort boosts the affective taste properties of food. Proc. R. Soc. B Bio. Sci. 2011, 278:1450-2145.
166. Juckel G., Schlagenhauf F., Koslowski M., Filonov D., Wustenberg T., Villringer A., Knutson B., Kienast T., Gallinat J., Wrase J., Heinz A. Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics. Psychopharmacology (Berl.) 2006, 187:222-228.
167. Juckel G., Schlagenhauf F., Koslowski M., Wustenberg T., Villringer A., Knutson B., Wrase J., Heinz A. Dysfunction of ventral striatal reward prediction in schizophrenia. NeuroImage 2006, 29:409-416.
168. Kaladjian A., Jeanningros R., Azorin J.M., Anton J.L., Mazzola-Pomietto P. Impulsivity and neural correlates of response inhibition in schizophrenia. Psychol. Med. 2011, 41:291-299.
169. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13:261-276.
170. Keefe R.S., Harvey P.D., Lenzenweger M.F., Davidson M., Apter S.H., Schmeidler J., Mohs R.C., Davis K.L. Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: negative symptoms. Psychiatry Res. 1992, 44:153-165.
171. Kelleher J.P., Centorrino F., Huxley N.A., Bates J.A., Drake J.K., Egli S., Baldessarini R.J. Pilot randomized, controlled trial of pramipexole to augment antipsychotic treatment. Eur. Neuropsychopharmacol. 2012, 22:415-418.
172. Kelley M.E., van Kammen D.P., Allen D.N. Empirical validation of primary negative symptoms: independence from effects of medication and psychosis. Am. J. Psychiatry 1999, 156:406-411.
173. Kennerley S.W., Behrens T.E., Wallis J.D. Double dissociation of value computations in orbitofrontal and anterior cingulate neurons. Nat. Neurosci. 2011, 14:1581-1589.
174. Kennerley S.W., Dahmubed A.F., Lara A.H., Wallis J.D. Neurons in the frontal lobe encode the value of multiple decision variables. J. Cogn. Neurosci. 2009, 21:1162-1178.
175. Kennerley S.W., Walton M.E. Decision making and reward in frontal cortex: complementary evidence from neurophysiological and neuropsychological studies. Behav. Neurosci. 2011, 125:297-317.
176. Kern R.S., Green M.F., Goldstein M.J. Modification of performance on the span of apprehension, a putative marker of vulnerability to schizophrenia. J. Abnorm. Psychol. 1995, 104:385-389.
177. Kerns J.G., Cohen J.D., MacDonald A.W., Johnson M.K., Stenger V.A., Aizenstein H., Carter C.S. Decreased conflict- and error-related activity in the anterior cingulate cortex in subjects with schizophrenia. Am. J. Psychiatry 2005, 162:1833-1839.
178. Kiang M., Christensen B.K., Remington G., Kapur S. Apathy in schizophrenia: clinical correlates and association with functional outcome. Schizophr. Res. 2003, 63:79-88.
179. Kim H., Lee D., Shin Y.M., Chey J. Impaired strategic decision making in schizophrenia. Brain Res. 2007, 1180:90-100.
180. Kimhy D., Yale S., Goetz R.R., McFarr L.M., Malaspina D. The factorial structure of the schedule for the deficit syndrome in schizophrenia. Schizophr. Bull. 2006, 32:274-278.
181. Kirkpatrick B., Fenton W.S., Carpenter W.T., Marder S.R. The NIMH-MATRICS consensus statement on negative symptoms. Schizophr. Bull. 2006, 32:214-219.
182. Kirkpatrick B., Strauss G.P., Nguyen L., Fischer B.A., Daniel D.G., Cienfuegos A., Marder S.R. The brief negative symptom scale: psychometric properties. Schizophr. Bull. 2011, 37:300-305.
183. Kishi T., Mukai T., Matsuda Y., Moriwaki M., Iwata N. Efficacy and safety of noradrenalin reuptake inhibitor augmentation therapy for schizophrenia: A meta-analysis of double-blind randomized placebo-controlled trials. J. Psychiatr. Res 2013, 10.1016/j.jpsychires.2013.07.003.
184. Kivetz R. The effects of effort and intrinsic motivation on risky choice. Market. Sci. 2003, 22:477-502.
185. Klein E.D., Bhatt R.S., Zentall T.R. Contrast and the justification of effort. Psychon. Bull. Rev. 2005, 12:335-339.
186. Klingberg S., Wolwer W., Engel C., Wittorf A., Herrlich J., Meisner C., Buchkremer G., Wiedemann G. Negative symptoms of schizophrenia as primary target of cognitive behavioral therapy: results of the randomized clinical TONES study. Schizophr. Bull. 2011, 37(Suppl 2):S98L 110.
187. Knutson B., Adams C.M., Fong G.W., Hommer D. Anticipation of increasing monetary reward selectively recruits nucleus accumbens. J. Neurosci. 2001, 21:RC159.
188. Knutson B., Fong G.W., Bennett S.M., Adams C.M., Hommer D. A region of mesial prefrontal cortex tracks monetarily rewarding outcomes: characterization with rapid event-related fMRI. NeuroImage 2003, 18:263-272.
189. Knutson B., Rick S., Wimmer G.E., Prelec D., Loewenstein G. Neural predictors of purchases. Neuron 2007, 53:147-156.
190. Koch K., Schachtzabel C., Wagner G., Schikora J., Schultz C., Reichenbach J.R., Sauer H., Schlosser R.G. Altered activation in association with reward-related trial-and-error learning in patients with schizophrenia. NeuroImage 2010, 50:223-232.
191. Konstantakopoulos G., Ploumpidis D., Oulis P., Patrikelis P., Soumani A., Papadimitriou G.N., Politis A.M. Apathy, cognitive deficits and functional impairment in schizophrenia. Schizophr. Res. 2011, 133:193-198.
192. Kool W., Botvinick M. A labor/leisure tradeoff in cognitive control. J. Exp. Psychol. Gen. 2012, 10.1037/a0031048.
193. Kool W., McGuire J.T., Rosen Z.B., Botvinick M.M. Decision making and the avoidance of cognitive demand. J. Exp. Psychol. Gen. 2010, 139:665-682.
194. Kopelowicz A., Ventura J., Liberman R.P., Mintz J. Consistency of Brief Psychiatric Rating Scale factor structure across a broad spectrum of schizophrenia patients. Psychopathology 2008, 41:77-84.
195. Kraepelin E. Dementia Praecox and Paraphrenia 1919, Livingstone, Edinburgh, UK.
196. Kring A.M., Gur R.E., Blanchard J.J., Horan W.P., Reise S.P. The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validation. Am. J. Psychiatry 2013, 170:165-172.
197. Kuha A., Suvisaari J., Perala J., Eerola M., Saarni S.S., Partonen T., Lonnqvist J., Tuulio-Henriksson A. Associations of anhedonia and cognition in persons with schizophrenia spectrum disorders, their siblings, and controls. J. Nerv. Ment. Dis. 2011, 199:30-37.
198. Kurniawan I.T., Guitart-Masip M., Dolan R.J. Dopamine and effort-based decision making. Front. Neurosci. 2011, 5:81.
199. Kurniawan I.T., Seymour B., Talmi D., Yoshida W., Chater N., Dolan R.J. Choosing to make an effort: the role of striatum in signaling physical effort of a chosen action. J. Neurophysiol. 2010, 104:313-321.
200. Laplane D., Dubois B. Auto-activation deficit: a basal ganglia related syndrome. Mov. Disord. 2001, 16:810-814.
201. Lasser R.A., Dirks B., Nasrallah H., Kirsch C., Gao J., Pucci M.L., Knesevich M.A., Lindenmayer J.P. Adjunctive lisdexamfetamine dimesylate therapy in adult outpatients with predominant negative symptoms of schizophrenia: open-label and randomized-withdrawal phases. Neuropsychopharmacology 2013, 38:2140-2149.
202. Laurent A., Duly D., Murry P., Foussard N., Boccara S., Mingat F., Dalery J., d'Amato T. WCST performance and schizotypal features in the first-degree relatives of patients with schizophrenia. Psychiatry Res. 2001, 104:133-144.
203. Lee D. Game theory and neural basis of social decision making. Nat. Neurosci. 2008, 11:404-409.
204. Lee D. Decision making: from neuroscience to psychiatry. Neuron 2013, 78:233-248.
205. Lee J., Park S. Working memory impairments in schizophrenia: a meta-analysis. J. Abnorm. Psychol. 2005, 114:599-611.
206. Lehman A.F., Lieberman J.A., Dixon L.B., McGlashan T.H., Miller A.L., Perkins D.O., Kreyenbuhl J. Practice guideline for the treatment of patients with schizophrenia, second edition. Am. J. Psychiatry 2004, 161:1-56.
207. Leung M., Cheung C., Yu K., Yip B., Sham P., Li Q., Chua S., McAlonan G. Gray matter in first-episode schizophrenia before and after antipsychotic drug treatment. Anatomical likelihood estimation meta-analyses with sample size weighting. Schizophr. Bull. 2011, 37:199-211.
208. Levi-Minzi S., Bermanzohn P.C., Siris S.G. Bromocriptine for "negative" schizophrenia. Compr. Psychiatry 1991, 32:210-216.
209. Levy R., Dubois B. Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cereb. Cortex 2006, 16:916-928.
210. Lewine R.R. A discriminant validity study of negative symptoms with a special focus on depression and antipsychotic medication. Am. J. Psychiatry 1990, 147:1463-1466.
211. Lieberman J.A., Kane J.M., Alvir J. Provocative tests with psychostimulant drugs in schizophrenia. Psychopharmacology (Berl.) 1987, 91:415-433.
212. Liemburg E., Castelein S., Stewart R., van der Gaag M., Aleman A., Knegtering H. Two subdomains of negative symptoms in psychotic disorders: established and confirmed in two large cohorts. J. Psychiatr. Res. 2013, 47:718-725.
213. Lindenmayer J.P., Nasrallah H., Pucci M., James S., Citrome L. A systematic review of psychostimulant treatment of negative symptoms of schizophrenia: challenges and therapeutic opportunities. Schizophr. Res. 2013, 147:241-252.
214. Llerena K., Strauss G.P., Cohen A.S. Looking at the other side of the coin: a meta-analysis of self-reported emotional arousal in people with schizophrenia. Schizophr. Res. 2012, 142:65-70.
215. Locke E.A. Toward a theory of task motivation and incentives. Org. Behav. Hum. Perform. 1968, 3:157-189.
216. Mai B., Sommer S., Hauber W. Motivational states influence effort-based decision making in rats: the role of dopamine in the nucleus accumbens. Cogn. Affect. Behav. Neurosci. 2012, 12:74-84.
217. Malenka R.C., Angel R.W., Hampton B., Berger P.A. Impaired central error-correcting behavior in schizophrenia. Arch. Gen. Psychiatry 1982, 39:101-107.
218. Malenka R.C., Angel R.W., Thiemann S., Weitz C.J., Berger P.A. Central error-correcting behavior in schizophrenia and depression. Biol. Psychiatry 1986, 21:263-273.
219. Malla A.K., Takhar J.J., Norman R.M., Manchanda R., Cortese L., Haricharan R., Verdi M., Ahmed R. Negative symptoms in first episode non-affective psychosis. Acta Psychiatr. Scand. 2002, 105:431-439.
220. Mann C.L., Footer O., Chung Y.S., Driscoll L.L., Barch D.M. Spared and impaired aspects of motivated cognitive control in schizophrenia. J. Abnorm. Psychol. 2013, 122:745-755.
221. Marder S.R., Daniel D.G., Alphs L., Awad A.G., Keefe R.S. Methodological issues in negative symptom trials. Schizophr. Bull. 2011, 37:250-254.
222. Marder S.R., Davis J.M., Chouinard G. The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials. J. Clin. Psychiatry 1997, 58:538-546.
223. Marin R.S., Biedrzycki R.C., Firinciogullari S. Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res. 1991, 38:143-162.
224. Marsman A., van den Heuvel M.P., Klomp D.W., Kahn R.S., Luijten P.R., Hulshoff Pol H.E. Glutamate in schizophrenia: a focused review and meta-analysis of (1)H-MRS studies. Schizophr. Bull. 2013, 39:120-129.
225. Maslow A.H. A theory of human motivation. Psychol. Rev. 1943, 50:370.
226. Mathews J., Newcomer J.W., Mathews J.R., Fales C.L., Pierce K.J., Akers B.K., Marcu I., Barch D.M. Neural correlates of weight gain with olanzapine. Arch. Gen. Psychiatry 2012, 69:1226-1237.
227. McGlashan T.H., Fenton W.S. The positive-negative distinction in schizophrenia. Review of natural history validators. Arch. Gen. Psychiatry 1992, 49:63-72.
228. McGuire J.T., Botvinick M.M. Prefrontal cortex, cognitive control, and the registration of decision costs. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:7922-7926.
229. Medalia A., Brekke J. In search of a theoretical structure for understanding motivation in schizophrenia. Schizophr. Bull. 2010, 36:912-918.
230. Meehl P.E. Schizotaxia, schizotypy, schizophrenia. Am. Psychol. 1962, 17:827-838.
231. Messinger J.W., Tremeau F., Antonius D., Mendelsohn E., Prudent V., Stanford A.D., Malaspina D. Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research. Clin. Psychol. Rev. 2011, 31:161-168.
232. Milev P., Ho B.C., Arndt S., Andreasen N.C. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am. J. Psychiatry 2005, 162:495-506.
233. Minas I.H., Klimidis S., Stuart G.W., Copolov D.L., Singh B.S. Positive and negative symptoms in the psychoses: principal components analysis of items from the Scale for the Assessment of Positive Symptoms and the Scale for the Assessment of Negative Symptoms. Compr. Psychiatry 1994, 35:135-144.
234. Minassian A., Henry B.L., Geyer M.A., Paulus M.P., Young J.W., Perry W. The quantitative assessment of motor activity in mania and schizophrenia. J. Affect. Disord. 2010, 120:200-206.
235. Mingote S., Font L., Farrar A.M., Vontell R., Worden L.T., Stopper C.M., Port R.G., Sink K.S., Bunce J.G., Chrobak J.J., Salamone J.D. Nucleus accumbens adenosine A2A receptors regulate exertion of effort by acting on the ventral striatopallidal pathway. J. Neurosci. 2008, 28:9037-9046.
236. Minzenberg M.J., Laird A.R., Thelen S., Carter C.S., Glahn D.C. Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia. Arch. Gen. Psychiatry 2009, 66:811-822.
237. Mizrahi R., Rusjan P., Agid O., Graff A., Mamo D.C., Zipursky R.B., Kapur S. Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: a PET study in schizophrenia. Am. J. Psychiatry 2007, 164:630-637.
238. Moberg P.J., Arnold S.E., Doty R.L., Kohler C., Kanes S., Seigel S., Gur R.E., Turetsky B.I. Impairment of odor hedonics in men with schizophrenia. Am. J. Psychiatry 2003, 160:1784-1789.
239. Mogenson G.J., Jones D.L., Yim C.Y. From motivation to action: functional interface between the limbic system and the motor system. Prog. Neurobiol. 1980, 14:69-97.
240. Morris R.W., Vercammen A., Lenroot R., Moore L., Langton J.M., Short B., Kulkarni J., Curtis J., O'Donnell M., Weickert C.S., Weickert T.W. Disambiguating ventral striatum fMRI-related BOLD signal during reward prediction in schizophrenia. Mol. Psychiatry 2012, 17(235):280-289.
241. Morris S.E., Cuthbert B.N. Research Domain Criteria: cognitive systems, neural circuits, and dimensions of behavior. Dialogues Clin. Neurosci. 2012, 14:29-37.
242. Mott A.M., Nunes E.J., Collins L.E., Port R.G., Sink K.S., Hockemeyer J., Muller C.E., Salamone J.D. The adenosine A2A antagonist MSX-3 reverses the effects of the dopamine antagonist haloperidol on effort-related decision making in a T-maze cost/benefit procedure. Psychopharmacology (Berl.) 2009, 204:103-112.
243. Mueser K.T., McGurk S.R. Schizophrenia. Lancet 2004, 363:2063-2072.
244. Mueser K.T., Sayers S.L., Schooler N.R., Mance R.M., Haas G.L. A multisite investigation of the reliability of the Scale for the Assessment of Negative Symptoms. Am. J. Psychiatry 1994, 151:1453-1462.
245. Murray G.K., Clark L., Corlett P.R., Blackwell A.D., Cools R., Jones P.B., Robbins T.W., Poustka L. Incentive motivation in first-episode psychosis: a behavioural study. BMC Psychiatry 2008, 8:34.
246. Murray G.K., Corlett P.R., Clark L., Pessiglione M., Blackwell A.D., Honey G., Jones P.B., Bullmore E.T., Robbins T.W., Fletcher P.C. Substantia nigra/ventral tegmental reward prediction error disruption in psychosis. Mol. Psychiatry 2008, 13(239):267-276.
247. Nakaya M., Ohmori K. A two-factor structure for the Schedule for the Deficit Syndrome in schizophrenia. Psychiatry Res. 2008, 158:256-259.
248. Nestler E.J., Carlezon W.A. The mesolimbic dopamine reward circuit in depression. Biol. Psychiatry 2006, 59:1151-1159.
249. Nicola S.M. The flexible approach hypothesis: unification of effort and cue-responding hypotheses for the role of nucleus accumbens dopamine in the activation of reward-seeking behavior. J. Neurosci. 2010, 30:16585-16600.
250. Nielsen M.O., Rostrup E., Wulff S., Bak N., Broberg B.V., Lublin H., Kapur S., Glenthoj B. Improvement of brain reward abnormalities by antipsychotic monotherapy in schizophrenia. Arch. Gen. Psychiatry 2012, 69:1195-1204.
251. Nielsen M.O., Rostrup E., Wulff S., Bak N., Lublin H., Kapur S., Glenthoj B. Alterations of the brain reward system in antipsychotic naive schizophrenia patients. Biol. Psychiatry 2012, 71:898-905.
252. Niv Y., Daw N.D., Joel D., Dayan P. Tonic dopamine: opportunity costs and the control of response vigor. Psychopharmacology (Berl.) 2007, 191:507-520.
253. Nolan K.A., D'Angelo D., Hoptman M.J. Self-report and laboratory measures of impulsivity in patients with schizophrenia or schizoaffective disorder and healthy controls. Psychiatry Res. 2011, 187:301-303.
254. Nordahl T.E., Carter C.S., Salo R.E., Kraft L., Baldo J., Salamat S., Robertson L., Kusubov N. Anterior cingulate metabolism correlates with stroop errors in paranoid schizophrenia patients. Neuropsychopharmacology 2001, 25:139-148.
255. Ohmori T., Koyama T., Inoue T., Matsubara S., Yamashita I. B-HT 920, a dopamine D2 agonist, in the treatment of negative symptoms of chronic schizophrenia. Biol. Psychiatry 1993, 33:687-693.
256. Oorschot M., Lataster T., Thewissen V., Lardinois M., Wichers M., van Os J., Delespaul P., Myin-Germeys I. Emotional experience in negative symptoms of schizophrenia - no evidence for a generalized hedonic deficit. Schizophr. Bull. 2013, 39:217-225.
257. Overall J.E., Donald R.G. The brief psychiatric rating scale. Psychol. Rep. 1962, 10:799-812.
258. Pardo M., Lopez-Cruz L., Valverde O., Ledent C., Baqi Y., Muller C.E., Salamone J.D., Correa M. Adenosine A2A receptor antagonism and genetic deletion attenuate the effects of dopamine D2 antagonism on effort-based decision making in mice. Neuropharmacology 2012, 62:2068-2077.
259. Pasquereau B., Turner R.S. Limited encoding of effort by dopamine neurons in a cost-benefit trade-off task. J. Neurosci. 2013, 33:8288-8300.
260. Paus T. Primate anterior cingulate cortex: where motor control, drive and cognition interface. Nat. Rev. Neurosci. 2001, 2:417-424.
261. Paus T., Koski L., Caramanos Z., Westbury C. Regional differences in the effects of task difficulty and motor output on blood flow response in the human anterior cingulate cortex: a review of 107 PET activation studies. NeuroReport 1998, 9:R37-47.
262. Penn D.L., Combs D. Modification of affect perception deficits in schizophrenia. Schizophr. Res. 2000, 46:217-229.
263. Peralta V., Cuesta M.J. Dimensional structure of psychotic symptoms: an item-level analysis of SAPS and SANS symptoms in psychotic disorders. Schizophr. Res. 1999, 38:13-26.
264. Perry W., Minassian A., Henry B., Kincaid M., Young J.W., Geyer M.A. Quantifying over-activity in bipolar and schizophrenia patients in a human open field paradigm. Psychiatry Res. 2010, 178:84-91.
265. Perry W., Minassian A., Paulus M.P., Young J.W., Kincaid M.J., Ferguson E.J., Henry B.L., Zhuang X., Masten V.L., Sharp R.F., Geyer M.A. A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men. Arch. Gen. Psychiatry 2009, 66:1072-1080.
266. Pessiglione M., Schmidt L., Draganski B., Kalisch R., Lau H., Dolan R.J., Frith C.D. How the brain translates money into force: a neuroimaging study of subliminal motivation. Science 2007, 316:904-906.
267. Pessiglione M., Seymour B., Flandin G., Dolan R.J., Frith C.D. Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans. Nature 2006, 442:1042-1045.
268. Phillips P.E., Walton M.E., Jhou T.C. Calculating utility: preclinical evidence for cost-benefit analysis by mesolimbic dopamine. Psychopharmacology (Berl.) 2007, 191:483-495.
269. Piskulic D., Addington J., Cadenhead K.S., Cannon T.D., Cornblatt B.A., Heinssen R., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., McGlashan T.H. Negative symptoms in individuals at clinical high risk of psychosis. Psychiatry Res. 2012, 196:220-224.
270. Plassmann H., O'Doherty J., Rangel A. Orbitofrontal cortex encodes willingness to pay in everyday economic transactions. J. Neurosci. 2007, 27:9984-9988.
271. Platt M.L., Huettel S.A. Risky business: the neuroeconomics of decision making under uncertainty. Nat. Neurosci. 2008, 11:398-403.
272. Pogue-Geile M.F., Harrow M. Negative symptoms in schizophrenia: their longitudinal course and prognostic importance. Schizophr. Bull. 1985, 11:427-439.
273. Polli F.E., Barton J.J., Thakkar K.N., Greve D.N., Goff D.C., Rauch S.L., Manoach D.S. Reduced error-related activation in two anterior cingulate circuits is related to impaired performance in schizophrenia. Brain 2008, 131:971-986.
274. Prevost C., Pessiglione M., Metereau E., Clery-Melin M.L., Dreher J.C. Separate valuation subsystems for delay and effort decision costs. J. Neurosci. 2010, 30:14080-14090.
275. Prikryl R., Kasparek T., Skotakova S., Ustohal L., Kucerova H., Ceskova E. Treatment of negative symptoms of schizophrenia using repetitive transcranial magnetic stimulation in a double-blind, randomized controlled study. Schizophr. Res. 2007, 95:151-157.
276. Rabinowitz J., Levine S.Z., Garibaldi G., Bugarski-Kirola D., Berardo C.G., Kapur S. Negative symptoms have greater impact on functioning than positive symptoms in schizophrenia: Analysis of CATIE data. Schizophr. Res. 2012, 137:147-150.
277. Rado S. Dynamics and classification of disordered behavior. Am. J. Psychiatry 1953, 110:406-416.
278. Raffard S., Esposito F., Boulenger J.P., Van der Linden M. Impaired ability to imagine future pleasant events is associated with apathy in schizophrenia. Psychiatry Res. 2013, 10.1016/j.psychres.2013.04.016.
279. Ragland J.D., Moelter S.T., Bhati M.T., Valdez J.N., Kohler C.G., Siegel S.J., Gur R.C., Gur R.E. Effect of retrieval effort and switching demand on fMRI activation during semantic word generation in schizophrenia. Schizophr. Res. 2008, 99:312-323.
280. Rangel A., Camerer C., Montague P.R. A framework for studying the neurobiology of value-based decision making. Nat. Rev. Neurosci. 2008, 9:545-556.
281. Rangel A., Hare T. Neural computations associated with goal-directed choice. Curr. Opin. Neurobiol. 2010, 20:262-270.
282. Rao N.P., Remington G. Investigational drugs for schizophrenia targeting the dopamine receptor: phase II trials. Expert Opin. Investig. Drugs 2013, 22:881-894.
283. Rassovsky Y., Green M.F., Nuechterlein K.H., Breitmeyer B., Mintz J. Modulation of attention during visual masking in schizophrenia. Am. J. Psychiatry 2005, 162:1533-1535.
284. Rector N.A., Beck A.T., Stolar N. The negative symptoms of schizophrenia: a cognitive perspective. Can. J. Psychiatry 2005, 50:247-257.
285. Reitan R.M., Wolfson D. Conation: a neglected aspect of neuropsychological functioning. Arch. Clin. Neuropsychol. 2000, 15:443-453.
286. Ribot T. La psychologie des Sentiments 1896, Felix Alcan, Paris.
287. Ridderinkhof K.R., Ullsperger M., Crone E.A., Nieuwenhuis S. The role of the medial frontal cortex in cognitive control. Science 2004, 306:443-447.
288. Robinson D.G., Woerner M.G., McMeniman M., Mendelowitz A., Bilder R.M. Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. Am. J. Psychiatry 2004, 161:473-479.
289. Roesch-Ely D., Gohring K., Gruschka P., Kaiser S., Pfuller U., Burlon M., Weisbrod M. Pergolide as adjuvant therapy to amisulpride in the treatment of negative and depressive symptoms in schizophrenia. Pharmacopsychiatry 2006, 39:115-116.
290. Roiser J.P., Stephan K.E., den Ouden H.E., Barnes T.R., Friston K.J., Joyce E.M. Do patients with schizophrenia exhibit aberrant salience?. Psychol. Med. 2009, 39:199-209.
291. Rosenheck R., Leslie D., Keefe R., McEvoy J., Swartz M., Perkins D., Stroup S., Hsiao J.K., Lieberman J. Barriers to employment for people with schizophrenia. Am. J. Psychiatry 2006, 163:411-417.
292. Roth R.M., Flashman L.A., Saykin A.J., McAllister T.W., Vidaver R. Apathy in schizophrenia: reduced frontal lobe volume and neuropsychological deficits. Am. J. Psychiatry 2004, 161:157-159.
293. Roth R.M., Koven N.S., Pendergrass J.C., Flashman L.A., McAllister T.W., Saykin A.J. Apathy and the processing of novelty in schizophrenia. Schizophr. Res. 2008, 98:232-238.
294. Rudebeck P.H., Walton M.E., Smyth A.N., Bannerman D.M., Rushworth M.F. Separate neural pathways process different decision costs. Nat. Neurosci. 2006, 9:1161-1168.
295. Rushworth M.F., Behrens T.E. Choice, uncertainty and value in prefrontal and cingulate cortex. Nat. Neurosci. 2008, 11:389-397.
296. Rushworth M.F., Behrens T.E., Rudebeck P.H., Walton M.E. Contrasting roles for cingulate and orbitofrontal cortex in decisions and social behaviour. Trends Cogn. Sci. 2007, 11:168-176.
297. Rushworth M.F., Kolling N., Sallet J., Mars R.B. Valuation and decision-making in frontal cortex: one or many serial or parallel systems?. Curr. Opin. Neurobiol. 2012, 22:946-955.
298. Rushworth M.F., Noonan M.P., Boorman E.D., Walton M.E., Behrens T.E. Frontal cortex and reward-guided learning and decision-making. Neuron 2011, 70:1054-1069.
299. Ryan R.M., Deci E.L. Self-determination theory and the facilitation of intrinsic motivation, social development, and well-being. Am. Psychol. 2000, 55:68-78.
300. Salamone J.D., Correa M. Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine. Behav. Brain Res. 2002, 137:3-25.
301. Salamone J.D., Correa M. The mysterious motivational functions of mesolimbic dopamine. Neuron 2012, 76:470-485.
302. Salamone J.D., Correa M., Farrar A., Mingote S.M. Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits. Psychopharmacology (Berl.) 2007, 191:461-482.
303. Salamone J.D., Cousins M.S., Bucher S. Anhedonia or anergia? Effects of haloperidol and nucleus accumbens dopamine depletion on instrumental response selection in a T-maze cost/benefit procedure. Behav. Brain Res. 1994, 65:221-229.
304. Salamone J.D., Steinpreis R.E., McCullough L.D., Smith P., Grebel D., Mahan K. Haloperidol and nucleus accumbens dopamine depletion suppress lever pressing for food but increase free food consumption in a novel food choice procedure. Psychopharmacology (Berl.) 1991, 104:515-521.
305. Sayers S.L., Curran P.J., Mueser K.T. Factor structure and construct validity of the Scale for the Assessment of Negative Symptoms. Psychol. Assess. 1996, 8:269.
306. Schlaepfer T.E., Cohen M.X., Frick C., Kosel M., Brodesser D., Axmacher N., Joe A.Y., Kreft M., Lenartz D., Sturm V. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology 2008, 33:368-377.
307. Schlagenhauf F., Juckel G., Koslowski M., Kahnt T., Knutson B., Dembler T., Kienast T., Gallinat J., Wrase J., Heinz A. Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine. Psychopharmacology (Berl.) 2008, 196:673-684.
308. Schlagenhauf F., Sterzer P., Schmack K., Ballmaier M., Rapp M., Wrase J., Juckel G., Gallinat J., Heinz A. Reward feedback alterations in unmedicated schizophrenia patients: relevance for delusions. Biol. Psychiatry 2009, 65:1032-1039.
309. Schmidt L., d'Arc B.F., Lafargue G., Galanaud D., Czernecki V., Grabli D., Schupbach M., Hartmann A., Levy R., Dubois B., Pessiglione M. Disconnecting force from money: effects of basal ganglia damage on incentive motivation. Brain 2008, 131:1303-1310.
310. Schmidt L., Lebreton M., Clery-Melin M.L., Daunizeau J., Pessiglione M. Neural mechanisms underlying motivation of mental versus physical effort. PLoS Biol. 2012, 10:e1001266.
311. Schurhoff F., Szoke A., Bellivier F., Turcas C., Villemur M., Tignol J., Rouillon F., Leboyer M. Anhedonia in schizophrenia: a distinct familial subtype?. Schizophr. Res. 2003, 61:59-66.
312. Schweimer J., Hauber W. Involvement of the rat anterior cingulate cortex in control of instrumental responses guided by reward expectancy. Learn. Mem. 2005, 12:334-342.
313. Schweimer J., Saft S., Hauber W. Involvement of catecholamine neurotransmission in the rat anterior cingulate in effort-related decision making. Behav. Neurosci. 2005, 119:1687-1692.
314. Selten J.P., Wiersma D., van den Bosch R.J. Distress attributed to negative symptoms in schizophrenia. Schizophr. Bull. 2000, 26:737-744.
315. Sergi M.J., Rassovsky Y., Widmark C., Reist C., Erhart S., Braff D.L., Marder S.R., Green M.F. Social cognition in schizophrenia: relationships with neurocognition and negative symptoms. Schizophr. Res. 2007, 90:316-324.
316. Sescousse G., Caldu X., Segura B., Dreher J.C. Processing of primary and secondary rewards: a quantitative meta-analysis and review of human functional neuroimaging studies. Neurosci. Biobehav. Rev. 2013, 37:681-696.
317. Shackman A.J., Salomons T.V., Slagter H.A., Fox A.S., Winter J.J., Davidson R.J. The integration of negative affect, pain and cognitive control in the cingulate cortex. Nat. Rev. Neurosci. 2011, 12:154-167.
318. Sharot T., De Martino B., Dolan R.J. How choice reveals and shapes expected hedonic outcome. J. Neurosci. 2009, 29:3760-3765.
319. Sharot T., Shiner T., Brown A.C., Fan J., Dolan R.J. Dopamine enhances expectation of pleasure in humans. Curr. Biol. 2009, 19:2077-2080.
320. Shenhav A., Botvinick M.M., Cohen J.D. The expected value of control: an integrative theory of anterior cingulate cortex function. Neuron 2013, 79:217-240.
321. Sherdell L., Waugh C.E., Gotlib I.H. Anticipatory pleasure predicts motivation for reward in major depression. J. Abnorm. Psychol. 2012, 121:51-60.
322. Shurman B., Horan W.P., Nuechterlein K.H. Schizophrenia patients demonstrate a distinctive pattern of decision-making impairment on the Iowa Gambling Task. Schizophr. Res. 2005, 72:215-224.
323. Simon J.J., Biller A., Walther S., Roesch-Ely D., Stippich C., Weisbrod M., Kaiser S. Neural correlates of reward processing in schizophrenia - relationship to apathy and depression. Schizophr. Res. 2010, 118:154-161.
324. Simon N.W., Beas B.S., Montgomery K.S., Haberman R.P., Bizon J.L., Setlow B. Prefrontal cortical-striatal dopamine receptor mRNA expression predicts distinct forms of impulsivity. Eur. J. Neurosci. 2013, 37:1779-1788.
325. Sitnikova T., Goff D., Kuperberg G.R. Neurocognitive abnormalities during comprehension of real-world goal-directed behaviors in schizophrenia. J. Abnorm. Psychol. 2009, 118:256-277.
326. Solinsky C., Kirby B.P. Medial prefrontal cortex lesions in mice do not impair effort-based decision making. Neuropharmacology 2013, 65:223-231.
327. Stephan K.E., Baldeweg T., Friston K.J. Synaptic plasticity and dysconnection in schizophrenia. Biol. Psychiatry 2006, 59:929-939.
328. Stevens J.R., Rosati A.G., Ross K.R., Hauser M.D. Will travel for food: spatial discounting in two new world monkeys. Curr. Biol. 2005, 15:1855-1860.
329. Strafella A.P., Paus T., Barrett J., Dagher A. Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. J. Neurosci. 2001, 21:RC157.
330. Strauss G.P., Frank M.J., Waltz J.A., Kasanova Z., Herbener E.S., Gold J.M. Deficits in positive reinforcement learning and uncertainty-driven exploration are associated with distinct aspects of negative symptoms in schizophrenia. Biol. Psychiatry 2011, 69:424-431.
331. Strauss G.P., Gold J.M. A new perspective on anhedonia in schizophrenia. Am. J. Psychiatry 2012, 169:364-373.
332. Strauss G.P., Hong L.E., Gold J.M., Buchanan R.W., McMahon R.P., Keller W.R., Fischer B.A., Catalano L.T., Culbreth A.J., Carpenter W.T., Kirkpatrick B. Factor structure of the Brief Negative Symptom Scale. Schizophr. Res. 2012, 142:96-98.
333. Strauss G.P., Wilbur R.C., Warren K.R., August S.M., Gold J.M. Anticipatory vs. consummatory pleasure: what is the nature of hedonic deficits in schizophrenia?. Psychiatry Res. 2011, 187:36-41.
334. Sugrue L.P., Corrado G.S., Newsome W.T. Choosing the greater of two goods: neural currencies for valuation and decision making. Nat. Rev. Neurosci. 2005, 6:363-375.
335. Summerfelt A.T., Alphs L.D., Funderburk F.R., Strauss M.E., Wagman A.M. Impaired Wisconsin Card Sort performance in schizophrenia may reflect motivational deficits. Arch. Gen. Psychiatry 1991, 48:282-283.
336. Summerfelt A.T., Alphs L.D., Wagman A.M., Funderburk F.R., Hierholzer R.M., Strauss M.E. Reduction of perseverative errors in patients with schizophrenia using monetary feedback. J. Abnorm. Psychol. 1991, 100:613-616.
337. Taylor S.F., Phan K.L., Britton J.C., Liberzon I. Neural response to emotional salience in schizophrenia. Neuropsychopharmacology 2005, 30:984-995.
338. Toomey R., Kremen W.S., Simpson J.C., Samson J.A., Seidman L.J., Lyons M.J., Faraone S.V., Tsuang M.T. Revisiting the factor structure for positive and negative symptoms: evidence from a large heterogeneous group of psychiatric patients. Am. J. Psychiatry 1997, 154:371-377.
339. Treadway M.T., Bossaller N.A., Shelton R.C., Zald D.H. Effort-based decision-making in major depressive disorder: a translational model of motivational anhedonia. J. Abnorm. Psychol. 2012, 121:553-558.
340. Treadway M.T., Buckholtz J.W., Cowan R.L., Woodward N.D., Li R., Ansari M.S., Baldwin R.M., Schwartzman A.N., Kessler R.M., Zald D.H. Dopaminergic mechanisms of individual differences in human effort-based decision-making. J. Neurosci. 2012, 32:6170-6176.
341. Treadway M.T., Buckholtz J.W., Schwartzman A.N., Lambert W.E., Zald D.H. Worth the 'EEfRT'? The effort expenditure for rewards task as an objective measure of motivation and anhedonia. PLoS ONE 2009, 4:e6598.
342. Treadway M.T., Zald D.H. Reconsidering anhedonia in depression: lessons from translational neuroscience. Neurosci. Biobehav. Rev. 2011, 35:537-555.
343. Tremeau F., Antonius D., Cacioppo J.T., Ziwich R., Butler P., Malaspina D., Javitt D.C. Anticipated, on-line and remembered positive experience in schizophrenia. Schizophr. Res. 2010, 122:199-205.
344. Tremeau F., Brady M., Saccente E., Moreno A., Epstein H., Citrome L., Malaspina D., Javitt D. Loss aversion in schizophrenia. Schizophr. Res. 2008, 103:121-128.
345. Tremeau F., Goldman J., Antonius D., Javitt D.C. Inpatients with schizophrenia report impaired situational motivation but intact global and social motivation. Psychiatry Res. 2013, 10.1016/j.psychres.2013.05.031.
346. Tremeau F., Nolan K.A., Malaspina D., Javitt D.C. Behavioral validation of avolition in schizophrenia. Schizophr. Res. 2012, 138:255-261.
347. Tversky A., Kahneman D. The framing of decisions and the psychology of choice. Science 1981, 211:453-458.
348. Uban K.A., Rummel J., Floresco S.B., Galea L.A. Estradiol modulates effort-based decision making in female rats. Neuropsychopharmacology 2012, 37:390-401.
349. Ursu S., Kring A.M., Gard M.G., Minzenberg M.J., Yoon J.H., Ragland J.D., Solomon M., Carter C.S. Prefrontal cortical deficits and impaired cognition-emotion interactions in schizophrenia. Am. J. Psychiatry 2011, 168:276-285.
350. van Kammen D.P., Boronow J.J. Dextro-amphetamine diminishes negative symptoms in schizophrenia. Int. Clin. Psychopharmacol. 1988, 3:111-121.
351. Van Putten T., May P.R., Marder S.R., Wittmann L.A. Subjective response to antipsychotic drugs. Arch. Gen. Psychiatry 1981, 38:187-190.
352. Venugopalan V.V., Casey K.F., O'Hara C., O'Loughlin J., Benkelfat C., Fellows L.K., Leyton M. Acute phenylalanine/tyrosine depletion reduces motivation to smoke cigarettes across stages of addiction. Neuropsychopharmacology 2011, 36:2469-2476.
353. Voruganti L., Awad A.G. Neuroleptic dysphoria: towards a new synthesis. Psychopharmacology (Berl.) 2004, 171:121-132.
354. Wallis J.D. Orbitofrontal cortex and its contribution to decision-making. Annu. Rev. Neurosci. 2007, 30:31-56.
355. Walsh R.N., Cummins R.A. The Open-Field Test: a critical review. Psychol. Bull. 1976, 83:482-504.
356. Walther S., Federspiel A., Horn H., Razavi N., Wiest R., Dierks T., Strik W., Muller T.J. Alterations of white matter integrity related to motor activity in schizophrenia. Neurobiol. Dis. 2011, 42:276-283.
357. Walther S., Federspiel A., Horn H., Razavi N., Wiest R., Dierks T., Strik W., Muller T.J. Resting state cerebral blood flow and objective motor activity reveal basal ganglia dysfunction in schizophrenia. Psychiatry Res. 2011, 192:117-124.
358. Walther S., Koschorke P., Horn H., Strik W. Objectively measured motor activity in schizophrenia challenges the validity of expert ratings. Psychiatry Res. 2009, 169:187-190.
359. Walton M.E., Bannerman D.M., Alterescu K., Rushworth M.F. Functional specialization within medial frontal cortex of the anterior cingulate for evaluating effort-related decisions. J. Neurosci. 2003, 23:6475-6479.
360. Walton M.E., Bannerman D.M., Rushworth M.F. The role of rat medial frontal cortex in effort-based decision making. J. Neurosci. 2002, 22:10996-11003.
361. Walton M.E., Croxson P.L., Rushworth M.F., Bannerman D.M. The mesocortical dopamine projection to anterior cingulate cortex plays no role in guiding effort-related decisions. Behav. Neurosci 2005, 119:323-328.
362. Walton M.E., Groves J., Jennings K.A., Croxson P.L., Sharp T., Rushworth M.F., Bannerman D.M. Comparing the role of the anterior cingulate cortex and 6-hydroxydopamine nucleus accumbens lesions on operant effort-based decision making. Eur. J. Neurosci. 2009, 29:1678-1691.
363. Walton M.E., Kennerley S.W., Bannerman D.M., Phillips P.E., Rushworth M.F. Weighing up the benefits of work: behavioral and neural analyses of effort-related decision making. Neural Netw. 2006, 19:1302-1314.
364. Walton M.E., Rudebeck P.H., Bannerman D.M., Rushworth M.F. Calculating the cost of acting in frontal cortex. Ann. N. Y. Acad. Sci. 2007, 1104:340-356.
365. Waltz J.A., Frank M.J., Robinson B.M., Gold J.M. Selective reinforcement learning deficits in schizophrenia support predictions from computational models of striatal-cortical dysfunction. Biol. Psychiatry 2007, 62:756-764.
366. Waltz J.A., Frank M.J., Wiecki T.V., Gold J.M. Altered probabilistic learning and response biases in schizophrenia: behavioral evidence and neurocomputational modeling. Neuropsychology 2011, 25:86-97.
367. Waltz J.A., Schweitzer J.B., Gold J.M., Kurup P.K., Ross T.J., Salmeron B.J., Rose E.J., McClure S.M., Stein E.A. Patients with schizophrenia have a reduced neural response to both unpredictable and predictable primary reinforcers. Neuropsychopharmacology 2009, 34:1567-1577.
368. Waltz J.A., Schweitzer J.B., Ross T.J., Kurup P.K., Salmeron B.J., Rose E.J., Gold J.M., Stein E.A. Abnormal responses to monetary outcomes in cortex, but not in the basal ganglia, in schizophrenia. Neuropsychopharmacology 2010, 35:2427-2439.
369. Ward R.D., Simpson E.H., Richards V.L., Deo G., Taylor K., Glendinning J.I., Kandel E.R., Balsam P.D. Dissociation of hedonic reaction to reward and incentive motivation in an animal model of the negative symptoms of schizophrenia. Neuropsychopharmacology 2012, 37:1699-1707.
370. Wardle M.C., Treadway M.T., de Wit H. Caffeine increases psychomotor performance on the effort expenditure for rewards task. Pharmacol. Biochem. Behav. 2012, 102:526-531.
371. Wardle M.C., Treadway M.T., Mayo L.M., Zald D.H., de Wit H. Amping up effort: effects of d-amphetamine on human effort-based decision-making. J. Neurosci. 2011, 31:16597-16602.
372. Waugh C.E., Gotlib I.H. Motivation for reward as a function of required effort: Dissociating the 'liking' from the 'wanting' system in humans. Motiv. Emotion 2008, 32:323-330.
373. Weiler J.A., Bellebaum C., Brune M., Juckel G., Daum I. Impairment of probabilistic reward-based learning in schizophrenia. Neuropsychology 2009, 23:571-580.
374. Westbrook A., Kester D., Braver T.S. What is the subjective cost of cognitive effort? Load, trait, and aging effects revealed by economic preference. PLoS ONE 2013, 8:e68210.
375. Wise R.A. Dopamine, learning and motivation. Nat. Rev. Neurosci. 2004, 5:483-494.
376. Worden L.T., Shahriari M., Farrar A.M., Sink K.S., Hockemeyer J., Muller C.E., Salamone J.D. The adenosine A2A antagonist MSX-3 reverses the effort-related effects of dopamine blockade: differential interaction with D1 and D2 family antagonists. Psychopharmacology (Berl.) 2009, 203:489-499.
377. Yilmaz A., Simsek F., Gonul A.S. Reduced reward-related probability learning in schizophrenia patients. Neuropsychiatr. Dis. Treat. 2012, 8:27-34.
378. Yung A.R., McGorry P.D. The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr. Bull. 1996, 22:353-370.
379. Zhornitsky S., Rizkallah E., Pampoulova T., Chiasson J.P., Lipp O., Stip E., Potvin S. Sensation-seeking, social anhedonia, and impulsivity in substance use disorder patients with and without schizophrenia and in non-abusing schizophrenia patients. Psychiatry Res. 2012, 200:237-241.